A newly identified PET imaging biomarker could help providers tailor immunotherapy treatments for patients with certain types of cancers. 

The new research, presented during ARRS 2024 in Boston, suggests CVD risk models may need to include certain findings identified in routine mammograms. 

The goal of the study is to obtain quantitative data on how daily training and competing affect players’ musculoskeletal health. The information will be used to inform training, rest and recovery periods. 

PAD patients evaluated with HeartFlow's noninvasive FFR_CT Analysis technology prior to surgery experienced much better outcomes, including a 63% lower risk of all-cause mortality after five years. 

The FDA has cleared over 150 artificial intelligence- or machine learning-enabled medical devices since the beginning of August.

Radiology is going though a period of disruption with a growing radiologist shortage, decreasing reimbursements and increasing numbers of exams, making workflow efficiency a critical concern.

Some believe it could make their jobs easier, while others perceive AI as a threat to their employment, new survey data suggest.

And with the help of deep learning techniques, it provides diagnostic quality imaging.

Dedicated teleradiology services could expand quality healthcare in regions where access and staffing shortages hinder patient care the most. 

Blue Earth will be sharing anonymized clinical data from its Phase 3 Lighthouse trial involving the use of PET imaging agent Posluma.